Effective quality control (QC) data management is essential for ensuring reliability of reported patient results and regulatory compliance in molecular infectious disease laboratories. This session ...

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key ...

Dealmaking was strong among molecular diagnostics (MDx) players during 2021 despite the continuation of the pandemic, with most merger and acquisition (M&A) transactions demonstrating either a pivot ...

The current pandemic has impacted nearly every aspect of daily life. One strategy to help public health professionals understand and control the spread of SARS-CoV-2 is the widespread testing of ...

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

FRANKLIN LAKES, N.J., Aug. 25, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has launched a new, fully ...

(Nanowerk Spotlight) Advanced molecular diagnostics tests that can rapidly and precisely detect diseases within the home could revolutionize preventive medicine and improve global biosecurity. Nucleic ...

In 2023, Danaher emerged as the top player in the molecular diagnostics market. The company's established presence within the US provides a strong foundation for expansion into emerging economies, ...

At the core of CTOAM's work, Morand explains, is a precision oncology process that integrates multiple diagnostic tools into ...

Across all included studies, AI-based diagnostic systems demonstrated high overall accuracy. When measured against expert ...